Skip to content

Warfarin: Patient Guide to Blood Thinning

Published: July 22, 2026Updated: July 22, 2026

Warfarin is an anticoagulant, or “blood thinner,” that reduces the risk of dangerous blood clots. It is used to treat or prevent clots, including those linked to deep vein thrombosis, pulmonary embolism, atrial fibrillation, and certain heart valve conditions. Your dose is adjusted using regular blood tests called INR measurements.

Quick summary

Warfarin can prevent serious clots, but it can also cause bleeding, so taking the correct dose and keeping regular INR appointments is essential. Never start, stop, or change your dose without guidance from your doctor or pharmacist.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 22, 2026Editorial policy

Key facts at a glance

ATC
B01AA03
Generic
Warfarin
Class
anticoagulant
Brands
Coumadin, Jantoven
Availability
rx
Pregnancy
X
Lactation
caution
Half-life (h)
40
Routes
oral
Forms
tablet
Regions
CN, US, EU, JP
Monitoring
coagulation, inr, dietary-vitamin-k

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
2-5mg once daily initially, maintenance 2-10mg once daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
0.1-0.2 mg/kg once daily initially, adjusted based on INR
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
1-3mg once daily initially, adjusted based on INR
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose above 25 mg may cause significant anticoagulation and bleeding risk
Chronic overdose: Prolonged INR greater than 4 indicates chronic over-anticoagulation
Immediate actions
Administer vitamin K, consider fresh frozen plasma or prothrombin complex concentrate, activated charcoal if within 1-2 hours of ingestion
Antidote
Vitamin K (phytonadione)(Highly effective for reversing warfarin-induced coagulopathy)
Poison Control: 1-800-222-1222

Special Populations

8 groups
✗

pregnancy

first trimester
unsafe
FDA Category
X
Dose Adjustment

avoid use

Key Recommendations

warfarin is contraindicated in first trimester due to risk of embryopathy including nasal hypoplasia, stippled epiphyses, and central nervous system abnormalities

Monitor

fetal ultrasound monitoring for anomalies

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

third trimester
unsafe
FDA Category
D
Dose Adjustment

avoid if possible

Key Recommendations

use only if benefits outweigh risks; consider switching to heparin

Monitor

close fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✓

lactation

breastfeeding
safe
FDA Category
N
Dose Adjustment

no adjustment needed

Key Recommendations

warfarin is considered compatible with breastfeeding; minimal excretion in breast milk

Monitor

routine infant follow-up

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

start at lower dose

Key Recommendations

initiate therapy at lower doses (e.g., 2-3mg) and monitor INR closely; increased sensitivity to anticoagulant effects

Monitor

frequent INR monitoring, assess for falls and bleeding

Use with caution and monitor for adverse effects.

⚠

pediatric_age

neonates and children
caution
FDA Category
N
Dose Adjustment

weight-based dosing with frequent adjustments

Key Recommendations

requires individualized dosing; vitamin K supplementation may be needed; venous access considerations

Monitor

frequent INR monitoring (often twice weekly during initiation)

Use with caution and monitor for adverse effects.

⚠

renal_impairment

all stages
caution
FDA Category
N
Dose Adjustment

no major dose reduction needed initially

Key Recommendations

warfarin is not renally excreted significantly; use standard initial dosing but monitor closely

Monitor

regular INR monitoring; assess renal function periodically

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

reduce dose initially

Key Recommendations

liver disease impairs synthesis of clotting factors and warfarin metabolism; start with lower dose

Monitor

frequent INR monitoring; monitor liver function tests

Use with caution and monitor for adverse effects.

✗

hepatic_impairment

severe
unsafe
FDA Category
N
Dose Adjustment

avoid or use extreme caution

Key Recommendations

severely impaired liver function markedly alters warfarin metabolism and clotting factor synthesis

Monitor

intensive monitoring if used

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

prescribingFDA
2023

FDA approval year

Value:1954

Year warfarin was first approved for medical use in the United States

drug_classWHO
2023

Drug class

Value:Anticoagulant (Vitamin K antagonist)

Warfarin belongs to the anticoagulant class of medications

usageMedical guidelines
2023

Common uses

Value:Prevention of blood clots, stroke prevention in atrial fibrillation, treatment of DVT and pulmonary embolism

Primary therapeutic applications of warfarin therapy

mechanismPharmacological literature
2023

Mechanism of action

Value:Inhibits vitamin K epoxide reductase, reducing synthesis of clotting factors II, VII, IX, and X

How warfarin works to prevent blood clot formation

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 22, 2026. · Read our editorial policy